<http://webisa.webdatacommons.org/26013812>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/26013812>	<http://www.w3.org/ns/prov#value>	"BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a definitive Asset Contribution Agreement with Geron Corporation (Nasdaq: GERN) to acquire the intellectual property, including patents and patent applications, and other assets related to Geron???s human embryonic stem (hES) cell programs consi" .
<http://webisa.webdatacommons.org/prov/462533485>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/26013812> .
<http://webisa.webdatacommons.org/26013812>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<marketplace.org> .
<http://webisa.webdatacommons.org/prov/103672564>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/26013812> .